313 related articles for article (PubMed ID: 17275984)
1. Lower urinary tract symptoms (LUTS) and sexual dysfunction (SD): new targets for new combination therapies?
Sciarra A
Eur Urol; 2007 Jun; 51(6):1485-7. PubMed ID: 17275984
[No Abstract] [Full Text] [Related]
2. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
Kaplan SA; Gonzalez RR; Te AE
Eur Urol; 2007 Jun; 51(6):1717-23. PubMed ID: 17258855
[TBL] [Abstract][Full Text] [Related]
3. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
Carson CC
BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
[TBL] [Abstract][Full Text] [Related]
4. Re: Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial: K. T. McVary, W. Monnig, J. L. Camps, Jr., J. M. Young, L. J. Tseng and G. van den Ende. J Urol 2007; 177: 1071-1077.
Ponholzer A; Rauchenwald M; Madersbacher S
J Urol; 2007 Sep; 178(3 Pt 1):1121-2; author reply 1122-3. PubMed ID: 17640682
[No Abstract] [Full Text] [Related]
5. [The positive effect of sildenafil on LUTS from BPH while treating ED].
Ying J; Yao D; Jiang Y; Ren X; Xu M
Zhonghua Nan Ke Xue; 2004 Sep; 10(9):681-3. PubMed ID: 15497711
[TBL] [Abstract][Full Text] [Related]
6. How many drugs for LUTS due to BPH are too many?
Andersson KE
J Urol; 2008 Sep; 180(3):811-2. PubMed ID: 18635235
[No Abstract] [Full Text] [Related]
7. Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.
Öztürk Mİ; Kalkan S; Koca O; Güneş M; Akyüz M; Karaman MI
Andrologia; 2012 May; 44 Suppl 1():791-5. PubMed ID: 22211956
[TBL] [Abstract][Full Text] [Related]
8. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
9. Male lower urinary tract symptoms and sildenafil.
Jackson G
Int J Clin Pract; 2007 Nov; 61(11):1779. PubMed ID: 17935539
[No Abstract] [Full Text] [Related]
10. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
Rosen RC
Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
[TBL] [Abstract][Full Text] [Related]
11. Erectile dysfunction and lower urinary tract symptoms secondary to BPH.
McVary KT
Eur Urol; 2005 Jun; 47(6):838-45. PubMed ID: 15925081
[TBL] [Abstract][Full Text] [Related]
12. Medical management of lower urinary tract symptoms in men: current treatment and future approaches.
Patel AK; Chapple CR
Nat Clin Pract Urol; 2008 Apr; 5(4):211-9. PubMed ID: 18301417
[TBL] [Abstract][Full Text] [Related]
13. Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men.
Mazur DJ; Helfand BT; McVary KT
Urol Clin North Am; 2012 Feb; 39(1):77-88. PubMed ID: 22118347
[TBL] [Abstract][Full Text] [Related]
14. Association between lower urinary tract symptoms and erectile dysfunction.
Seftel AD
J Urol; 2005 Jun; 173(6):2077-8. PubMed ID: 15879840
[No Abstract] [Full Text] [Related]
15. Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.
Crawford ED
BJU Int; 2005 Jun; 95 Suppl 4():1-5. PubMed ID: 15871729
[No Abstract] [Full Text] [Related]
16. Re: Efficacy of alfuzosin and sildenafil combination in male patients with lower urinary tract symptoms.
Kaplan SA
J Urol; 2013 Sep; 190(3):978. PubMed ID: 23931214
[No Abstract] [Full Text] [Related]
17. Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.
Seftel A
J Urol; 2005 Nov; 174(5):1940-1. PubMed ID: 16217354
[No Abstract] [Full Text] [Related]
18. [The effectiveness of naftopidil in patients with benign prostatic hyperplasia evaluated by QOL index].
Nakatsu H; Naoi M; Sekiyama K; Hamano S; Suzuki N; Tanaka M; Murakami S
Hinyokika Kiyo; 2007 Jan; 53(1):13-8. PubMed ID: 17310763
[TBL] [Abstract][Full Text] [Related]
19. Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function.
Kaplan SA
Urology; 2004 Mar; 63(3):428-34. PubMed ID: 15028431
[No Abstract] [Full Text] [Related]
20. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
Seftel A; Rosen R; Kuritzky L
Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
